Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1977-04-12
1979-07-10
Marantz, Sidney
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
23230B, 424 12, G01N 3316, G01N 2152
Patent
active
041608186
ABSTRACT:
Substituted hydantoin drugs (for example phenytoin) and tricyclic antidepressant drugs (for example nortriptyline) are assayed by mixing them with a fluorescent labelled compound and antibodies, and measuring the fluorescence of the mixture. The assay does not necessitate any separation step and may be effected by continuous-flow techniques.
REFERENCES:
patent: 2797149 (1957-06-01), Skeggs
patent: 3901654 (1975-08-01), Gross
patent: 3995021 (1976-11-01), Gross
patent: 3996345 (1976-12-01), Ullman
patent: 3998943 (1976-12-01), Ullman
patent: 4036946 (1977-07-01), Kleinerman
McGregor Adrienne R.
Smith David S.
Marantz Sidney
Salzman Robert S.
Technicon Instruments Corporation
Tedesco S. P.
LandOfFree
Fluorimetric immunoassay for diphenylhydantoin does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Fluorimetric immunoassay for diphenylhydantoin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fluorimetric immunoassay for diphenylhydantoin will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-739256